Skip to main content
OpenTrials

Clinical trial condition

Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Explore clinical trials studying Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Advanced Gastric or Gastroesophageal Junction Adenocarcinoma trial results

Recruiting

JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.

NCT07284134

Conditions
Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Locations
  • AnHui Provincial Cancer Hospital Hefei, Anhui, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital Fuzhou, Fujian, China
View all 68 locations
View Trial Details
Active, Not Recruiting

Second-line Treatment With Serplulimab, Lenvatinib, and Paclitaxel in Advanced Gastric Cancer After Prior Immunotherapy

NCT05585580

Conditions
Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Locations
  • Qilu hospital of Shandong univertisy Jinan, Shandong, China
  • Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan, Shandong, China
  • The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital) Jinan, Shandong, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details

Related conditions